Larry Luchsinger

Principle Investigator of Hematopoietic Stem Cell biology laboratory & director of iPSC banking with a demonstrated history of making fundamental discoveries.

[Mohamad Mohty @Mohty_EBMT]

Please join ⁦@TheIACH⁩ to celebrate Dr ⁦@Narla_ASH2024⁩ who is the current president of ⁦@ASH_hematology⁩
https://t.co/M8uAvpTKIk
⁦@NYBloodCenter⁩ ⁦@ASHClinicalNews⁩ ⁦@ASTCT⁩ ⁦@BloodJournal⁩ ⁦@BloodAdvances⁩ ⁦@EHA_Hematology⁩

[City of New York @nycgov]

In case you need an extra push to donate blood, NewYork-Presbyterian Hospital and chef Dominique Ansel have teamed up to create 3 Lives Bar, a new chocolate bar that you'll only get if you give blood with the New York Blood Center.

https://t.co/08XwWBD2rG

[HemaSphere Journal (prelim IF = 11.3) @Hemasphere_EHA]

🎉Our first 2024 issue is finally online, with more papers coming next week! https://t.co/4zOVVr99Ro
We're proud to now publish with Wiley, offering easy submission, transformative agreements (many authors will incur zero APCs!), + much more. Lots of good changes, all while we hold close our priorities of excellent science, accessibility, & low fees.

[Larry Luchsinger @L_Luchsinger]

I'm deeply saddened by the loss of Dr. Connie Eaves, a remarkable scientist at @BCCancer’s @tfri_research & professor at @UBC. Connie's pioneering work in translational stem cell research leaves a lasting mark, and her legacy will be dearly cherished. #StemCell #UBC #ISEH #ISSCR

[Larry Luchsinger @L_Luchsinger]

Recent aticle from Dr. Katherine MacNamara, Professor of Immunology and Microbial Diseases, @UAlbany Medical School, who spoke last month at LFKRI. Great work. https://t.co/Pmd7Efst8K

[Larry Luchsinger @L_Luchsinger]

I am grateful for the dedication and hard work of my incredible team on this #EmployeeAppreciationDay. Their passion for hematology and tireless efforts drive our research forward. Thank you all or being the backbone of LFKRI.

[Larry Luchsinger @L_Luchsinger]

Excited for our next cohort of Future Leaders in Science to visit this week! The LFKRI program allows local NY-area high schoolers access to our labs and an opportunity to visualize a career in research. Thank you @IronResearchLab for supporting and managing this program.

[Larry Luchsinger @L_Luchsinger]

Great podcast featuring my colleage @IronResearchLab: https://t.co/ivT0M9sD28

[BioIronSocial @BioIronSocial]

Heme Alert 🔋 🩸
For who is interested in learning a bit about hemolysis and the toxic effects of free heme in hemolytic anemias, have a look to this podcast from our very own Francesca Vinchi @IronResearchLab interviewed by Roberta Foresti
https://t.co/B8jn1jMdrj via @YouTube

[Eric Topol @EricTopol]

Selective targeting and accelerated aging of dopamine neurons by #SARSCoV2 (derived from human pluripotent stem cells), also seen at patient autopsy, and blunted by metformin and 2 other drugs
https://t.co/o1q13SsbTd @liuliuyang1 @ChenShuibing

[Larry Luchsinger @L_Luchsinger]

Reading @deCarvalhoRenan paper on #clonal replacement and germinal centers in respiratory illness. Great work. https://t.co/TaAJXDSjKS

[Larry Luchsinger @L_Luchsinger]

Dr. Sankaran (@bloodgenes) spoke recently at LFKRI about his recent work. Very fascinating!

[Vijay Sankaran @bloodgenes]

Fantastic to have our paper "Deciphering cell states and genealogies of human hematopoiesis" published today in @Nature as an Accelerated Article Preview! We describe ReDeeM! Awesome work led by @chenweng1991 in a wonderful collaboration with @JswLab!

https://t.co/7RGJWdGcM2

[Larry Luchsinger @L_Luchsinger]

I am incredibly proud of @Narla_ASH2024 and his recent appointment as the 2024 ASH President. As my LFKRI Director predecessor, Dr. Narla and I have worked together for many years. I am certain his expertise will be an incredible addition to @ASH_Hematology

[Larry Luchsinger @L_Luchsinger]

Excited to have Jennifer Raab as the new @NYSCFpresident. I'm looking forward seeing her initiatives enacted throughout the year. Congrats, Jennifer! @NYSCF #StemCell

[Larry Luchsinger @L_Luchsinger]

@nyscfpresident @nyscf Congratulations, Jennifer.

[Larry Luchsinger @L_Luchsinger]

During a blood emergency, the absence of blood can impede our progress in advancing critical research causes in the #hematology field. Just one of the many reasons becoming a #regulardonor is important.

[NY Blood Center @NYBloodCenter]

Our blood supply is in critical condition. Increased cold, flu, RSV, and Covid-19 cases, along with recent weather challenges, have strained our supply. Your immediate help is crucial to replenish our supply.

Schedule an appt or walk in to donate today: https://t.co/qPYmRGjQ2R

[NY Blood Center @NYBloodCenter]

NYBC has declared a blood emergency, as our region's #bloodsupply is critically low. Hospitals and patients depend on your lifesaving donations.

Everyone has the power to help; please schedule an appointment or walk in to donate today. https://t.co/qPYmRGknSp

[NY Blood Center @NYBloodCenter]

Join us at @UBSArena on January 16, for the @NYIslanders blood drive. 🏒🩸 . As our way of saying thank you, all presenting donors will receive a voucher for two tickets to an upcoming game. #NYIslanders

Schedule your appointment here: https://t.co/3hbXNVPzaQ

[NY Blood Center @NYBloodCenter]

Your donation could be the lifeline someone desperately needs. ❤️ Schedule an appointment for this week and enjoy the holidays even more knowing that you saved up to three lives in less than an hour: https://t.co/7oPXnc1zHb

[Larry Luchsinger @L_Luchsinger]

Congratulations, @brucesachais!

[Science News @ScienceNews]

The FDA has approved the first CRISPR-based medicine But the fact that the drug fills an unmet need for underserved patients is “more compelling to me, personally, than the fact that it’s CRISPR.” https://t.co/QEr2LUhX4q